Loading insider details...
Beta
Latest Form 4 (Sep 3, 2026): Tax Withholding of 2,079 TRDA shares, $14.9K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 3, 2026 | Entrada Therapeutics, Inc. (TRDA) | Tax Withholding | 2,079 | $14.9K |
| May 4, 2026 | Entrada Therapeutics, Inc. (TRDA) | Sale | 25,907 | $398.8K |
| Mar 3, 2026 | Entrada Therapeutics, Inc. (TRDA) | Grant/Award | 55,800 | n/a |
| Sep 4, 2025 | Entrada Therapeutics, Inc. (TRDA) | Tax Withholding | 1,760 | $9.6K |
| Mar 4, 2025 | Entrada Therapeutics, Inc. (TRDA) | Grant/Award | 60,800 | n/a |
| Dec 3, 2024 | Entrada Therapeutics, Inc. (TRDA) | Sale | 100 | $2.0K |
| Nov 13, 2024 | Entrada Therapeutics, Inc. (TRDA) | Sale | 1,409 | $28.2K |
| Nov 6, 2024 | Entrada Therapeutics, Inc. (TRDA) | Sale | 749 | $13.5K |
| Oct 18, 2024 | Entrada Therapeutics, Inc. (TRDA) | Sale | 600 | $10.8K |
| Sep 10, 2024 | Entrada Therapeutics, Inc. (TRDA) | Sale | 600 | $9.1K |